A detailed history of Price T Rowe Associates Inc transactions in Si Bone, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 20,494 shares of SIBN stock, worth $266,422. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,494
Previous 19,122 7.17%
Holding current value
$266,422
Previous $402,000 16.42%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$15.15 - $21.58 $20,785 - $29,607
1,372 Added 7.17%
20,494 $336,000
Q4 2023

Feb 14, 2024

BUY
$15.75 - $21.38 $34,870 - $47,335
2,214 Added 13.09%
19,122 $402,000
Q3 2023

Nov 14, 2023

SELL
$20.22 - $27.36 $33,383 - $45,171
-1,651 Reduced 8.9%
16,908 $360,000
Q2 2023

Aug 14, 2023

BUY
$19.39 - $28.9 $11,362 - $16,935
586 Added 3.26%
18,559 $501,000
Q1 2023

May 15, 2023

BUY
$12.71 - $21.17 $5,808 - $9,674
457 Added 2.61%
17,973 $354,000
Q4 2022

Feb 14, 2023

BUY
$11.23 - $19.44 $8,343 - $14,443
743 Added 4.43%
17,516 $238,000
Q3 2022

Nov 14, 2022

BUY
$12.2 - $18.71 $46,652 - $71,547
3,824 Added 29.53%
16,773 $293,000
Q2 2022

Aug 15, 2022

BUY
$12.05 - $22.74 $20,629 - $38,930
1,712 Added 15.24%
12,949 $171,000
Q1 2022

May 16, 2022

SELL
$18.32 - $23.03 $13,098 - $16,466
-715 Reduced 5.98%
11,237 $254,000
Q4 2021

Feb 14, 2022

SELL
$18.75 - $24.8 $1,987 - $2,628
-106 Reduced 0.88%
11,952 $265,000
Q3 2021

Nov 15, 2021

BUY
$19.65 - $31.89 $56,022 - $90,918
2,851 Added 30.97%
12,058 $258,000
Q2 2021

Aug 16, 2021

BUY
$29.4 - $35.96 $19,521 - $23,877
664 Added 7.77%
9,207 $290,000
Q1 2021

May 17, 2021

SELL
$28.09 - $34.02 $78,820 - $95,460
-2,806 Reduced 24.72%
8,543 $272,000
Q4 2020

Feb 16, 2021

BUY
$20.44 - $30.88 $231,973 - $350,457
11,349 New
11,349 $339,000

Others Institutions Holding SIBN

About SI-BONE, Inc.


  • Ticker SIBN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,305,000
  • Market Cap $446M
  • Description
  • SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...
More about SIBN
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.